Table: RaQualia Pharma -2020 parent results
Feb 12 (Reuters)-
RaQualia Pharma Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2020 Dec 31, 2019 Dec 31, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 1.10 1.69
(-40.2 pct) (+128.7 pct)
Operating loss 512 mln 62 mln
Recurring loss 550 mln 92 mln
Net loss 654 mln 79 mln
EPS loss 31.26 yen 3.86 yen
EPS Diluted 3.85 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - RaQualia Pharma Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T